c-Rel anticorps (AA 569-619)
Aperçu rapide pour c-Rel anticorps (AA 569-619) (ABIN7451669)
Antigène
Voir toutes c-Rel AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 569-619
-
Fonction
- Rabbit anti-c-Rel Antibody, Affinity Purified
-
Purification
- Affinity Purified
-
Immunogène
- between AA 569 and 619
-
Isotype
- IgG
-
-
-
-
Indications d'application
-
IP: 2 - 5 μg/mg lysate
WB: 1:2,000 - 1:10,000
-
Restrictions
- For Research Use only
-
-
-
Concentration
- 1000 μg/mL
-
Buffer
- Tris-citrate/phosphate buffer, pH 7 to 8 containing 0.09 % Sodium Azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C
-
Date de péremption
- 12 months
-
-
- c-Rel (REL proto-oncogene (c-Rel))
-
Autre désignation
- c-Rel
-
Sujet
- Background: c-Rel is one of five monomeric subunits that are part of the Rel family of proteins that dimerize to form the NF-kappa B (nuclear factor that binds the kappa immunoglobulin light chain gene enhancer) transcription factor. Members of the Rel family of proteins include NF-kappa B1/p50, NF-kappa B2/p52, RelA/p65, c-Rel, and RelB. Each Rel member bears a characteristic 300 amino acid N-terminal Rel homology domain (RHD). c-Rel was originally identified as the cellular version of the v-Rel oncogene derived from the avian reticuloendotheliosis retrovirus.
-
ID gène
- 5966
-
NCBI Accession
- NP_002899
-
UniProt
- Q04864
Antigène
-